86.90.E - Other human health activities notelsewhere classified
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | -0,1 | -0,1 | -3,5 |
EBITDA | 1,7 | 0,3 | 0,2 | -42,7 |
Short time liabilities | 2,8 | 3,9 | 1,8 | -53,7 |
Equity capital | 1,1 | 0,2 | 0,1 | -6 |
Operating profit (EBIT) | 1,6 | 0,2 | 0,1 | -60,4 |
Assets | 6,4 | 5,1 | 2,8 | -46,4 |
Net profit (loss) | 1,5 | -0,2 | -0,1 | 33 |
Cash | 0,6 | 0,3 | 0 | -82,4 |
Net income from sale | 6,3 | 4,8 | 3,5 | -28 |
Liabilities and provisions for liabilities | 5,3 | 5 | 2,6 | -47,7 |
Working assets | 2,6 | 2,5 | 0,2 | -91 |
Depreciation | 0,1 | 0,1 | 0,1 | -13,9 |
% | % | % | p.p. | |
Profitability of capital | 130,2 | -120,9 | -86,2 | 34,7 |
Equity capital to total assets | 17,9 | 3,1 | 5,4 | 2,3 |
Gross profit margin | 23,5 | -2,3 | -3,3 | -1 |
EBITDA Margin | 27,5 | 6,2 | 4,9 | -1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 161 | 297 | 191 | -106 |
Current financial liquidity indicator | 0.878143846988678 | 0.6412930488586426 | 0.12429889291524887 | -0,5 |
Net dept to EBITDA | 1.9075431823730469 | 10.793850898742676 | 11.703847885131836 | 0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane